| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 68 | 2023 | 6882 | 2.340 |
Why?
|
| Genome-Wide Association Study | 95 | 2021 | 12261 | 2.230 |
Why?
|
| Polymorphism, Single Nucleotide | 115 | 2021 | 15519 | 2.190 |
Why?
|
| Genetic Predisposition to Disease | 107 | 2022 | 17446 | 2.160 |
Why?
|
| Sleep | 26 | 2024 | 4623 | 2.020 |
Why?
|
| DNA Copy Number Variations | 19 | 2019 | 1941 | 1.780 |
Why?
|
| Linkage Disequilibrium | 32 | 2019 | 1997 | 1.350 |
Why?
|
| Bipolar Disorder | 37 | 2021 | 5027 | 1.350 |
Why?
|
| Genetic Variation | 36 | 2021 | 6544 | 1.190 |
Why?
|
| Electroencephalography | 12 | 2023 | 6150 | 1.130 |
Why?
|
| Genome, Human | 25 | 2016 | 4420 | 1.110 |
Why?
|
| Multifactorial Inheritance | 12 | 2018 | 1194 | 1.060 |
Why?
|
| Chromosome Mapping | 26 | 2019 | 4740 | 0.980 |
Why?
|
| Quantitative Trait Loci | 17 | 2022 | 2019 | 0.960 |
Why?
|
| Genetic Linkage | 11 | 2019 | 2421 | 0.920 |
Why?
|
| Models, Genetic | 27 | 2018 | 3494 | 0.870 |
Why?
|
| Gene Frequency | 32 | 2018 | 3588 | 0.860 |
Why?
|
| Snoring | 1 | 2023 | 191 | 0.850 |
Why?
|
| Twins | 6 | 2020 | 339 | 0.850 |
Why?
|
| Genetic Loci | 15 | 2019 | 2575 | 0.830 |
Why?
|
| Genotype | 60 | 2021 | 12951 | 0.730 |
Why?
|
| Haplotypes | 22 | 2014 | 2779 | 0.720 |
Why?
|
| Calcium Channels, L-Type | 8 | 2017 | 240 | 0.710 |
Why?
|
| Case-Control Studies | 63 | 2020 | 21746 | 0.690 |
Why?
|
| Software | 8 | 2015 | 4443 | 0.660 |
Why?
|
| Technology | 1 | 2021 | 305 | 0.660 |
Why?
|
| Genetics, Population | 13 | 2015 | 934 | 0.620 |
Why?
|
| Alleles | 34 | 2021 | 6933 | 0.600 |
Why?
|
| Genetics, Behavioral | 4 | 2020 | 53 | 0.560 |
Why?
|
| Quantitative Trait, Heritable | 11 | 2018 | 544 | 0.540 |
Why?
|
| Genetic Markers | 15 | 2017 | 2634 | 0.530 |
Why?
|
| Exons | 7 | 2019 | 2437 | 0.520 |
Why?
|
| Environment | 7 | 2007 | 1124 | 0.480 |
Why?
|
| Phenotype | 32 | 2023 | 16365 | 0.480 |
Why?
|
| Sleep Apnea, Obstructive | 6 | 2023 | 1813 | 0.470 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2014 | 587 | 0.450 |
Why?
|
| Nerve Tissue Proteins | 15 | 2019 | 4462 | 0.440 |
Why?
|
| Twin Studies as Topic | 2 | 2020 | 105 | 0.440 |
Why?
|
| Genetic Phenomena | 1 | 2012 | 5 | 0.440 |
Why?
|
| Humans | 240 | 2024 | 744343 | 0.430 |
Why?
|
| Polysomnography | 10 | 2023 | 1776 | 0.430 |
Why?
|
| Depressive Disorder, Major | 13 | 2019 | 4644 | 0.430 |
Why?
|
| Sequence Analysis, DNA | 7 | 2022 | 4803 | 0.420 |
Why?
|
| Sleep, REM | 5 | 2022 | 595 | 0.420 |
Why?
|
| Nuclear Family | 4 | 2007 | 318 | 0.400 |
Why?
|
| Social Environment | 4 | 2007 | 1023 | 0.390 |
Why?
|
| Models, Statistical | 8 | 2011 | 5102 | 0.380 |
Why?
|
| Population | 2 | 2008 | 142 | 0.380 |
Why?
|
| Biostatistics | 1 | 2012 | 162 | 0.370 |
Why?
|
| Actigraphy | 3 | 2023 | 488 | 0.350 |
Why?
|
| Epistasis, Genetic | 3 | 2012 | 365 | 0.350 |
Why?
|
| Heterozygote | 3 | 2015 | 2804 | 0.350 |
Why?
|
| Sweden | 11 | 2019 | 1345 | 0.340 |
Why?
|
| Life Change Events | 4 | 2016 | 938 | 0.340 |
Why?
|
| Chromosomes, Human, X | 4 | 2018 | 296 | 0.330 |
Why?
|
| Synapses | 6 | 2017 | 1728 | 0.330 |
Why?
|
| Lithium Carbonate | 1 | 2009 | 184 | 0.330 |
Why?
|
| Oxyhemoglobins | 2 | 2019 | 216 | 0.320 |
Why?
|
| Myosin Type V | 1 | 2008 | 34 | 0.320 |
Why?
|
| Sleep Deprivation | 3 | 2024 | 832 | 0.310 |
Why?
|
| Male | 118 | 2023 | 350118 | 0.310 |
Why?
|
| Genetic Association Studies | 8 | 2021 | 2703 | 0.300 |
Why?
|
| Cytoskeletal Proteins | 7 | 2017 | 1364 | 0.300 |
Why?
|
| Intelligence | 4 | 2017 | 920 | 0.300 |
Why?
|
| Sleep Stages | 4 | 2023 | 686 | 0.300 |
Why?
|
| Mutation | 15 | 2020 | 29786 | 0.300 |
Why?
|
| Pedigree | 11 | 2014 | 4644 | 0.290 |
Why?
|
| Child Development Disorders, Pervasive | 5 | 2014 | 615 | 0.290 |
Why?
|
| Cognition | 5 | 2023 | 6770 | 0.290 |
Why?
|
| Disease | 2 | 2015 | 680 | 0.280 |
Why?
|
| Female | 123 | 2023 | 380194 | 0.280 |
Why?
|
| Cognition Disorders | 6 | 2017 | 4043 | 0.280 |
Why?
|
| Medical History Taking | 2 | 2008 | 783 | 0.280 |
Why?
|
| Biotechnology | 1 | 2008 | 281 | 0.280 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 414 | 0.280 |
Why?
|
| Family | 7 | 2015 | 3147 | 0.280 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2022 | 1004 | 0.270 |
Why?
|
| GTPase-Activating Proteins | 3 | 2019 | 498 | 0.260 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2014 | 4266 | 0.250 |
Why?
|
| Brain | 8 | 2023 | 26385 | 0.250 |
Why?
|
| Inheritance Patterns | 5 | 2015 | 340 | 0.250 |
Why?
|
| Ankyrins | 4 | 2017 | 128 | 0.250 |
Why?
|
| Psychotic Disorders | 7 | 2019 | 3046 | 0.250 |
Why?
|
| p21-Activated Kinases | 2 | 2016 | 128 | 0.250 |
Why?
|
| Genome | 2 | 2011 | 1808 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2019 | 460 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2010 | 380 | 0.230 |
Why?
|
| Depressive Disorder | 5 | 2016 | 3748 | 0.230 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 2838 | 0.220 |
Why?
|
| Gene Dosage | 4 | 2019 | 1252 | 0.220 |
Why?
|
| Nuclear Proteins | 4 | 2017 | 5853 | 0.220 |
Why?
|
| Genetic Techniques | 2 | 2008 | 435 | 0.220 |
Why?
|
| Antipsychotic Agents | 4 | 2016 | 3057 | 0.220 |
Why?
|
| Databases, Genetic | 7 | 2016 | 1783 | 0.220 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2022 | 783 | 0.220 |
Why?
|
| Computer Simulation | 14 | 2015 | 6196 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 3597 | 0.210 |
Why?
|
| Homozygote | 8 | 2015 | 1785 | 0.210 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2021 | 944 | 0.210 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 10 | 2013 | 3658 | 0.210 |
Why?
|
| Genetic Testing | 3 | 2014 | 3444 | 0.210 |
Why?
|
| Informatics | 1 | 2022 | 72 | 0.210 |
Why?
|
| Membrane Glycoproteins | 3 | 2008 | 3768 | 0.200 |
Why?
|
| Domestic Violence | 1 | 2003 | 176 | 0.190 |
Why?
|
| Polymorphism, Genetic | 6 | 2017 | 4328 | 0.190 |
Why?
|
| Tourette Syndrome | 2 | 2014 | 379 | 0.190 |
Why?
|
| Mental Disorders | 6 | 2016 | 6600 | 0.180 |
Why?
|
| Calcium Channels, T-Type | 1 | 2020 | 34 | 0.180 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2023 | 271 | 0.180 |
Why?
|
| Child of Impaired Parents | 1 | 2004 | 455 | 0.180 |
Why?
|
| Heme | 1 | 2022 | 307 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1988 | 0.180 |
Why?
|
| Clozapine | 3 | 2016 | 498 | 0.180 |
Why?
|
| Adult | 56 | 2023 | 214055 | 0.180 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2019 | 18 | 0.170 |
Why?
|
| Fragile X Mental Retardation Protein | 3 | 2016 | 117 | 0.170 |
Why?
|
| Dementia | 2 | 2023 | 2518 | 0.170 |
Why?
|
| Ferrochelatase | 1 | 2019 | 46 | 0.170 |
Why?
|
| Sequence Deletion | 4 | 2013 | 1526 | 0.170 |
Why?
|
| Triglycerides | 1 | 2007 | 2454 | 0.170 |
Why?
|
| Hexokinase | 1 | 2019 | 125 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2012 | 535 | 0.160 |
Why?
|
| Meta-Analysis as Topic | 7 | 2017 | 1344 | 0.160 |
Why?
|
| Middle Aged | 47 | 2023 | 213383 | 0.160 |
Why?
|
| Sample Size | 6 | 2020 | 845 | 0.160 |
Why?
|
| Upper Extremity | 1 | 2023 | 648 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2013 | 403 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2009 | 1414 | 0.160 |
Why?
|
| Osteoporotic Fractures | 1 | 2023 | 401 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2017 | 11725 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 5 | 2014 | 2716 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2009 | 374 | 0.150 |
Why?
|
| Probability | 1 | 2023 | 2505 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2014 | 354 | 0.150 |
Why?
|
| Endophenotypes | 2 | 2017 | 250 | 0.150 |
Why?
|
| Depression | 7 | 2016 | 7766 | 0.150 |
Why?
|
| Genes | 2 | 2012 | 1893 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2014 | 3920 | 0.150 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3445 | 0.150 |
Why?
|
| Chromosome Duplication | 2 | 2014 | 74 | 0.150 |
Why?
|
| Risk | 8 | 2019 | 9687 | 0.150 |
Why?
|
| Child | 23 | 2023 | 77709 | 0.140 |
Why?
|
| Carrier Proteins | 5 | 2015 | 5021 | 0.140 |
Why?
|
| Adolescent | 29 | 2023 | 85781 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2916 | 0.140 |
Why?
|
| Gene Deletion | 4 | 2013 | 2751 | 0.140 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 19905 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2011 | 473 | 0.140 |
Why?
|
| Logistic Models | 9 | 2015 | 13408 | 0.140 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 12072 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2915 | 0.140 |
Why?
|
| Obsessive-Compulsive Disorder | 3 | 2014 | 1444 | 0.140 |
Why?
|
| Aged | 28 | 2023 | 163280 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2007 | 284 | 0.130 |
Why?
|
| DNA Mutational Analysis | 10 | 2016 | 4186 | 0.130 |
Why?
|
| Dendritic Spines | 1 | 2016 | 233 | 0.130 |
Why?
|
| Self Report | 7 | 2020 | 3558 | 0.130 |
Why?
|
| Prion Diseases | 1 | 2016 | 88 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 3 | 2012 | 936 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 514 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Base Sequence | 7 | 2013 | 12797 | 0.120 |
Why?
|
| DNA, Intergenic | 1 | 2014 | 107 | 0.120 |
Why?
|
| Cohort Studies | 19 | 2020 | 40561 | 0.120 |
Why?
|
| Severity of Illness Index | 8 | 2022 | 15540 | 0.120 |
Why?
|
| Likelihood Functions | 4 | 2015 | 1005 | 0.120 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 32 | 0.120 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11727 | 0.120 |
Why?
|
| Nervous System | 1 | 2017 | 554 | 0.120 |
Why?
|
| Penetrance | 1 | 2016 | 381 | 0.120 |
Why?
|
| Carbohydrate Epimerases | 1 | 2013 | 43 | 0.120 |
Why?
|
| Body Height | 2 | 2010 | 1577 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2014 | 895 | 0.120 |
Why?
|
| Genealogy and Heraldry | 1 | 2013 | 28 | 0.120 |
Why?
|
| Child, Preschool | 10 | 2023 | 41006 | 0.110 |
Why?
|
| Computational Biology | 4 | 2019 | 3521 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 186 | 0.110 |
Why?
|
| Histocompatibility, Maternal-Fetal | 1 | 2012 | 11 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2012 | 417 | 0.110 |
Why?
|
| Multiple Sclerosis | 3 | 2015 | 3079 | 0.110 |
Why?
|
| Alpha-Globulins | 1 | 2012 | 29 | 0.110 |
Why?
|
| Fibrillar Collagens | 1 | 2012 | 41 | 0.110 |
Why?
|
| Genes, Recessive | 1 | 2015 | 641 | 0.110 |
Why?
|
| Suicide, Attempted | 2 | 2011 | 1221 | 0.110 |
Why?
|
| Risk Factors | 26 | 2018 | 72290 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2022 | 967 | 0.110 |
Why?
|
| Blood | 1 | 2014 | 598 | 0.100 |
Why?
|
| Loss of Heterozygosity | 2 | 2013 | 684 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2015 | 3712 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 191 | 0.100 |
Why?
|
| Menorrhagia | 1 | 2012 | 63 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 670 | 0.100 |
Why?
|
| Finland | 4 | 2017 | 602 | 0.100 |
Why?
|
| Diseases in Twins | 2 | 2007 | 449 | 0.100 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 52 | 0.100 |
Why?
|
| Regression Analysis | 6 | 2018 | 6459 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 323 | 0.100 |
Why?
|
| Hemophilia B | 1 | 2012 | 81 | 0.100 |
Why?
|
| Lithium Compounds | 2 | 2015 | 225 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2014 | 810 | 0.100 |
Why?
|
| Personality | 2 | 2008 | 552 | 0.100 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2007 | 52 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2012 | 1375 | 0.100 |
Why?
|
| Gene Expression | 4 | 2019 | 7799 | 0.100 |
Why?
|
| Age Factors | 5 | 2020 | 18370 | 0.100 |
Why?
|
| Algorithms | 9 | 2015 | 13881 | 0.090 |
Why?
|
| Fasting | 1 | 2017 | 1593 | 0.090 |
Why?
|
| Demography | 2 | 2013 | 1656 | 0.090 |
Why?
|
| Reference Values | 6 | 2010 | 4982 | 0.090 |
Why?
|
| Internet | 1 | 2003 | 3064 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2014 | 6038 | 0.090 |
Why?
|
| von Willebrand Diseases | 1 | 2012 | 127 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 1534 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2014 | 622 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 658 | 0.090 |
Why?
|
| Twins, Dizygotic | 3 | 2007 | 236 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
| Complement C7 | 1 | 2009 | 17 | 0.090 |
Why?
|
| Waist-Hip Ratio | 1 | 2010 | 517 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2849 | 0.080 |
Why?
|
| Aryldialkylphosphatase | 1 | 2009 | 63 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2017 | 3864 | 0.080 |
Why?
|
| Neurofibromatosis 2 | 2 | 2003 | 380 | 0.080 |
Why?
|
| Crohn Disease | 4 | 2013 | 2303 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 975 | 0.080 |
Why?
|
| Twins, Monozygotic | 3 | 2007 | 458 | 0.080 |
Why?
|
| Young Adult | 13 | 2019 | 56430 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 478 | 0.080 |
Why?
|
| Hemophilia A | 1 | 2012 | 351 | 0.080 |
Why?
|
| Anxiety Disorders | 3 | 2016 | 2690 | 0.080 |
Why?
|
| Founder Effect | 1 | 2008 | 189 | 0.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 1028 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2503 | 0.080 |
Why?
|
| Genomics | 4 | 2016 | 5720 | 0.080 |
Why?
|
| Autistic Disorder | 2 | 2016 | 1185 | 0.080 |
Why?
|
| RGS Proteins | 1 | 2008 | 77 | 0.080 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2011 | 1953 | 0.080 |
Why?
|
| Age of Onset | 6 | 2014 | 3271 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 7913 | 0.080 |
Why?
|
| Autoantigens | 1 | 2012 | 892 | 0.080 |
Why?
|
| Anger | 2 | 2007 | 402 | 0.080 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2008 | 58 | 0.080 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2007 | 66 | 0.080 |
Why?
|
| Genetic Research | 1 | 2008 | 174 | 0.080 |
Why?
|
| Citalopram | 2 | 2008 | 403 | 0.080 |
Why?
|
| Neurotic Disorders | 2 | 2004 | 79 | 0.080 |
Why?
|
| Receptors, AMPA | 1 | 2009 | 331 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 504 | 0.070 |
Why?
|
| Introns | 2 | 2007 | 991 | 0.070 |
Why?
|
| Language Development Disorders | 2 | 1999 | 196 | 0.070 |
Why?
|
| Receptors, Cannabinoid | 1 | 2006 | 44 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2012 | 1381 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2012 | 1169 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2007 | 94 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 944 | 0.070 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 1987 | 58 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 13989 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2007 | 118 | 0.070 |
Why?
|
| Glucokinase | 1 | 2007 | 103 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2023 | 57776 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2007 | 147 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2006 | 52 | 0.070 |
Why?
|
| Social Control, Formal | 1 | 2007 | 110 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 457 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1178 | 0.070 |
Why?
|
| Multivariate Analysis | 4 | 2013 | 12245 | 0.070 |
Why?
|
| Complement Factor H | 1 | 2006 | 110 | 0.070 |
Why?
|
| Dyslexia | 1 | 2008 | 248 | 0.070 |
Why?
|
| Parents | 6 | 2012 | 3407 | 0.070 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2005 | 28 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6365 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 216 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2011 | 4554 | 0.070 |
Why?
|
| Mosaicism | 2 | 2013 | 441 | 0.070 |
Why?
|
| Selection, Genetic | 2 | 2007 | 914 | 0.070 |
Why?
|
| Temperament | 1 | 2008 | 283 | 0.070 |
Why?
|
| Europe | 4 | 2016 | 3339 | 0.070 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 15165 | 0.070 |
Why?
|
| DNA | 3 | 2008 | 7301 | 0.070 |
Why?
|
| Turner Syndrome | 1 | 2006 | 130 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 873 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5867 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 597 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 1814 | 0.070 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 175 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2014 | 1774 | 0.070 |
Why?
|
| Schizophrenic Psychology | 2 | 2016 | 1678 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2019 | 4286 | 0.060 |
Why?
|
| Microsatellite Repeats | 4 | 2011 | 802 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2014 | 2072 | 0.060 |
Why?
|
| Health Surveys | 2 | 2013 | 4037 | 0.060 |
Why?
|
| Sulpiride | 1 | 2004 | 17 | 0.060 |
Why?
|
| Gene Duplication | 2 | 2018 | 329 | 0.060 |
Why?
|
| Nerve Net | 2 | 2014 | 2174 | 0.060 |
Why?
|
| Odds Ratio | 6 | 2017 | 9849 | 0.060 |
Why?
|
| Hydrolases | 1 | 2005 | 139 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2010 | 1159 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2010 | 1114 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2013 | 373 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3462 | 0.060 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 151 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2005 | 195 | 0.060 |
Why?
|
| Dreams | 1 | 1986 | 147 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2942 | 0.060 |
Why?
|
| RNA | 2 | 2013 | 2749 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 142 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3589 | 0.060 |
Why?
|
| Sampling Studies | 2 | 2003 | 623 | 0.060 |
Why?
|
| Sex Characteristics | 3 | 2020 | 2585 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2008 | 981 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 1456 | 0.060 |
Why?
|
| Chi-Square Distribution | 4 | 2006 | 3508 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2009 | 1782 | 0.060 |
Why?
|
| Antisocial Personality Disorder | 1 | 2005 | 228 | 0.060 |
Why?
|
| Mood Disorders | 1 | 2010 | 1106 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3703 | 0.060 |
Why?
|
| Matched-Pair Analysis | 2 | 2001 | 288 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2624 | 0.060 |
Why?
|
| Dissociative Disorders | 1 | 2005 | 231 | 0.060 |
Why?
|
| Anxiety | 4 | 2016 | 4297 | 0.060 |
Why?
|
| Chromosome Breakpoints | 2 | 2014 | 98 | 0.060 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2004 | 191 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1462 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2010 | 1124 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 18111 | 0.050 |
Why?
|
| Germany | 3 | 2011 | 862 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2014 | 2972 | 0.050 |
Why?
|
| Violence | 1 | 2009 | 909 | 0.050 |
Why?
|
| Chromatin | 1 | 2014 | 2934 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1832 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 2015 | 0.050 |
Why?
|
| Marijuana Abuse | 1 | 2006 | 403 | 0.050 |
Why?
|
| Sex Factors | 6 | 2019 | 10397 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2007 | 2924 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2017 | 287 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 927 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1530 | 0.050 |
Why?
|
| Neuropsychological Tests | 4 | 2017 | 6993 | 0.050 |
Why?
|
| Lod Score | 3 | 2013 | 614 | 0.050 |
Why?
|
| Social Behavior | 3 | 2016 | 1127 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2007 | 747 | 0.050 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2002 | 124 | 0.050 |
Why?
|
| Insulin | 1 | 2017 | 6580 | 0.050 |
Why?
|
| Family Health | 3 | 2012 | 1282 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3386 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2256 | 0.050 |
Why?
|
| Software Design | 1 | 2002 | 176 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2008 | 1609 | 0.050 |
Why?
|
| Siblings | 4 | 2008 | 854 | 0.050 |
Why?
|
| Statistics, Nonparametric | 3 | 2017 | 2886 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8664 | 0.050 |
Why?
|
| Sibling Relations | 1 | 2001 | 45 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8037 | 0.050 |
Why?
|
| Neurophysiology | 1 | 2022 | 142 | 0.050 |
Why?
|
| Scotland | 2 | 2013 | 155 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2016 | 733 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2005 | 627 | 0.050 |
Why?
|
| London | 2 | 2011 | 233 | 0.050 |
Why?
|
| Alcoholism | 1 | 2011 | 1906 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2022 | 263 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 742 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 3617 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7722 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2013 | 351 | 0.050 |
Why?
|
| Signal Transduction | 6 | 2021 | 23403 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2373 | 0.040 |
Why?
|
| Smoking | 2 | 2007 | 8987 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2007 | 1210 | 0.040 |
Why?
|
| Proteins | 1 | 2015 | 6103 | 0.040 |
Why?
|
| Self Concept | 1 | 1986 | 1025 | 0.040 |
Why?
|
| Blood Volume | 1 | 2001 | 565 | 0.040 |
Why?
|
| Body Weight | 1 | 2010 | 4669 | 0.040 |
Why?
|
| Ireland | 2 | 2010 | 161 | 0.040 |
Why?
|
| Work Schedule Tolerance | 1 | 2024 | 565 | 0.040 |
Why?
|
| Cadherins | 2 | 2011 | 907 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2002 | 475 | 0.040 |
Why?
|
| Dystrophin-Associated Proteins | 2 | 2010 | 61 | 0.040 |
Why?
|
| Oxygen | 2 | 2022 | 4189 | 0.040 |
Why?
|
| Autoantibodies | 1 | 1987 | 2035 | 0.040 |
Why?
|
| Quality Control | 2 | 2012 | 841 | 0.040 |
Why?
|
| Macular Degeneration | 1 | 2006 | 980 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2023 | 53288 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 2015 | 1117 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 1999 | 152 | 0.040 |
Why?
|
| Prevalence | 3 | 2019 | 15226 | 0.040 |
Why?
|
| Neuroma, Acoustic | 1 | 2002 | 451 | 0.040 |
Why?
|
| Personality Inventory | 3 | 2007 | 1030 | 0.040 |
Why?
|
| Fear | 1 | 2006 | 1440 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2016 | 430 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2019 | 265 | 0.040 |
Why?
|
| Fatigue | 1 | 2005 | 1531 | 0.040 |
Why?
|
| Child Behavior Disorders | 1 | 2002 | 807 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2421 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 1425 | 0.040 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2016 | 11 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2016 | 72 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 2 | 2007 | 33 | 0.040 |
Why?
|
| Canada | 1 | 2022 | 2065 | 0.040 |
Why?
|
| Aminopeptidases | 1 | 2017 | 88 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7880 | 0.040 |
Why?
|
| Neuronal Plasticity | 2 | 2016 | 1422 | 0.040 |
Why?
|
| Suicide | 1 | 2007 | 1477 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 418 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2018 | 224 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2003 | 1320 | 0.030 |
Why?
|
| Comorbidity | 4 | 2014 | 10388 | 0.030 |
Why?
|
| Portugal | 2 | 2005 | 87 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2013 | 1586 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 35421 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4215 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2017 | 249 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 469 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3752 | 0.030 |
Why?
|
| Xenopus laevis | 2 | 1996 | 957 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2015 | 162 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 849 | 0.030 |
Why?
|
| beta Catenin | 2 | 2016 | 1059 | 0.030 |
Why?
|
| Genetic Code | 1 | 2014 | 154 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 3966 | 0.030 |
Why?
|
| Prions | 1 | 2016 | 180 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 363 | 0.030 |
Why?
|
| Child Abuse | 1 | 2003 | 1030 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1534 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2019 | 852 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 1072 | 0.030 |
Why?
|
| Internationality | 2 | 2010 | 1003 | 0.030 |
Why?
|
| Minisatellite Repeats | 2 | 2005 | 165 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1774 | 0.030 |
Why?
|
| Mass Screening | 1 | 2009 | 5255 | 0.030 |
Why?
|
| Education | 1 | 2016 | 543 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2007 | 422 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2400 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 917 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2010 | 12720 | 0.030 |
Why?
|
| Michigan | 1 | 2013 | 350 | 0.030 |
Why?
|
| Research | 1 | 2021 | 1999 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 176 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 1106 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2007 | 6256 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 4217 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 581 | 0.030 |
Why?
|
| Lithium | 1 | 2015 | 601 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2013 | 235 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 780 | 0.030 |
Why?
|
| Post-Synaptic Density | 1 | 2011 | 11 | 0.030 |
Why?
|
| Bulgaria | 1 | 2011 | 25 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2013 | 322 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 528 | 0.030 |
Why?
|
| AIDS-Related Complex | 1 | 2011 | 110 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2020 | 2740 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14557 | 0.030 |
Why?
|
| Heart Rate | 1 | 2023 | 4091 | 0.030 |
Why?
|
| Marital Status | 1 | 2013 | 437 | 0.030 |
Why?
|
| Antimanic Agents | 1 | 2015 | 522 | 0.030 |
Why?
|
| Germ-Line Mutation | 2 | 2014 | 1788 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2012 | 326 | 0.030 |
Why?
|
| Iceland | 1 | 2011 | 183 | 0.030 |
Why?
|
| Trisomy | 1 | 2013 | 266 | 0.020 |
Why?
|
| Animals | 10 | 2020 | 168757 | 0.020 |
Why?
|
| Health Status | 1 | 2005 | 4034 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2016 | 553 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2014 | 338 | 0.020 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 7785 | 0.020 |
Why?
|
| Africa | 1 | 2013 | 673 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 1285 | 0.020 |
Why?
|
| PubMed | 1 | 2011 | 123 | 0.020 |
Why?
|
| Clone Cells | 1 | 2014 | 1692 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2001 | 2731 | 0.020 |
Why?
|
| Time Factors | 2 | 2023 | 40075 | 0.020 |
Why?
|
| Lysine | 1 | 2015 | 1007 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6487 | 0.020 |
Why?
|
| Interviews as Topic | 2 | 2008 | 2539 | 0.020 |
Why?
|
| Adrenomedullin | 1 | 2010 | 87 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14722 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1708 | 0.020 |
Why?
|
| Lactase | 1 | 2010 | 69 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 635 | 0.020 |
Why?
|
| Lipase | 1 | 2012 | 314 | 0.020 |
Why?
|
| United States | 5 | 2021 | 69872 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 141 | 0.020 |
Why?
|
| Histone Chaperones | 1 | 2010 | 76 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 1996 | 1005 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1801 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2309 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 2008 | 0.020 |
Why?
|
| Selection Bias | 1 | 2011 | 371 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2004 | 7729 | 0.020 |
Why?
|
| Research Design | 1 | 2005 | 5987 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2010 | 613 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 25043 | 0.020 |
Why?
|
| Confidentiality | 1 | 2013 | 612 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 1678 | 0.020 |
Why?
|
| Jews | 1 | 2010 | 385 | 0.020 |
Why?
|
| Quebec | 1 | 2008 | 134 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 767 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1538 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 367 | 0.020 |
Why?
|
| Vocabulary | 2 | 1999 | 169 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 1179 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1987 | 163 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2010 | 336 | 0.020 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 798 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 144 | 0.020 |
Why?
|
| Pteroylpolyglutamic Acids | 1 | 2007 | 10 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2008 | 75 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 461 | 0.020 |
Why?
|
| China | 1 | 2013 | 2248 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1730 | 0.020 |
Why?
|
| Japan | 1 | 2011 | 1360 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.020 |
Why?
|
| Social Alienation | 1 | 2006 | 19 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 627 | 0.020 |
Why?
|
| Individuality | 2 | 1999 | 307 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39050 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4204 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9438 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2008 | 462 | 0.020 |
Why?
|
| Adiposity | 1 | 2016 | 1807 | 0.020 |
Why?
|
| Vietnam Conflict | 1 | 2007 | 99 | 0.020 |
Why?
|
| Colorado | 1 | 2006 | 163 | 0.020 |
Why?
|
| Mental Processes | 1 | 2008 | 249 | 0.020 |
Why?
|
| Rodentia | 1 | 2008 | 261 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1799 | 0.020 |
Why?
|
| Sugar Acids | 1 | 1985 | 24 | 0.020 |
Why?
|
| Antiporters | 1 | 2007 | 277 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 658 | 0.020 |
Why?
|
| Lipid A | 1 | 1985 | 67 | 0.020 |
Why?
|
| Receptor, Serotonin, 5-HT1D | 1 | 2005 | 9 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 1406 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 867 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2007 | 339 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 851 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2005 | 65 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2540 | 0.020 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2005 | 44 | 0.020 |
Why?
|
| Data Mining | 1 | 2010 | 537 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 669 | 0.020 |
Why?
|
| Israel | 1 | 2008 | 796 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2715 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2564 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 2599 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2005 | 89 | 0.020 |
Why?
|
| Glycolipids | 1 | 1985 | 204 | 0.020 |
Why?
|
| DNA Primers | 2 | 2003 | 2892 | 0.020 |
Why?
|
| Neurons | 2 | 2016 | 9338 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 8436 | 0.020 |
Why?
|
| Markov Chains | 1 | 2008 | 969 | 0.020 |
Why?
|
| Combat Disorders | 1 | 2007 | 302 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 2005 | 178 | 0.020 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2004 | 108 | 0.020 |
Why?
|
| Fetus | 1 | 2012 | 1880 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 3144 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2012 | 2617 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2007 | 467 | 0.020 |
Why?
|
| Proteomics | 1 | 2017 | 3638 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2005 | 791 | 0.010 |
Why?
|
| Mice | 3 | 2020 | 81183 | 0.010 |
Why?
|
| Homocysteine | 1 | 2007 | 647 | 0.010 |
Why?
|
| Hippocampus | 1 | 2016 | 3675 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1985 | 351 | 0.010 |
Why?
|
| Menopause | 1 | 2011 | 1626 | 0.010 |
Why?
|
| Symporters | 1 | 2006 | 362 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 604 | 0.010 |
Why?
|
| Review Literature as Topic | 1 | 2005 | 336 | 0.010 |
Why?
|
| South Africa | 1 | 2008 | 1731 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 322 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1987 | 2505 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2007 | 675 | 0.010 |
Why?
|
| Multigene Family | 1 | 2006 | 1102 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 2356 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13815 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9386 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 335 | 0.010 |
Why?
|
| Peer Group | 1 | 2007 | 635 | 0.010 |
Why?
|
| Gene Pool | 1 | 2001 | 35 | 0.010 |
Why?
|
| North America | 1 | 2005 | 1249 | 0.010 |
Why?
|
| Taiwan | 1 | 2003 | 496 | 0.010 |
Why?
|
| Crime Victims | 1 | 2005 | 322 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2002 | 171 | 0.010 |
Why?
|
| Ohio | 1 | 2001 | 337 | 0.010 |
Why?
|
| Parenting | 1 | 2007 | 679 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77449 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2005 | 811 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8949 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3846 | 0.010 |
Why?
|
| Consciousness | 1 | 1986 | 572 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 1792 | 0.010 |
Why?
|
| Obstetric Labor Complications | 1 | 2002 | 238 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8340 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8089 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1987 | 3870 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 819 | 0.010 |
Why?
|
| Impulsive Behavior | 1 | 2002 | 316 | 0.010 |
Why?
|
| Stem Cells | 1 | 2012 | 3567 | 0.010 |
Why?
|
| Affect | 1 | 2007 | 1476 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 13033 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3279 | 0.010 |
Why?
|
| Adolescent Behavior | 1 | 2007 | 1151 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2002 | 850 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2000 | 977 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1940 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 5456 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1758 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 19229 | 0.010 |
Why?
|
| Wnt1 Protein | 1 | 1996 | 118 | 0.010 |
Why?
|
| Emotions | 1 | 2008 | 2661 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1996 | 281 | 0.010 |
Why?
|
| Microinjections | 1 | 1996 | 327 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 7322 | 0.010 |
Why?
|
| RNA Caps | 1 | 1995 | 74 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9583 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4258 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4026 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29063 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 494 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6489 | 0.010 |
Why?
|
| Gestational Age | 1 | 2002 | 3493 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 9959 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 1996 | 433 | 0.010 |
Why?
|
| Veterans | 1 | 2007 | 2519 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1950 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 1996 | 721 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1995 | 895 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2001 | 2050 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 12208 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2000 | 2616 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 23338 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 2861 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 12745 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 21827 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15076 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 3772 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 35136 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11366 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2002 | 25625 | 0.000 |
Why?
|
| Species Specificity | 1 | 1985 | 2478 | 0.000 |
Why?
|
| Pregnancy | 1 | 2002 | 29144 | 0.000 |
Why?
|
| Temperature | 1 | 1985 | 2206 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1985 | 2203 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 3760 | 0.000 |
Why?
|
| Lipids | 1 | 1985 | 3305 | 0.000 |
Why?
|